Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

BMI and vitamin D were significantly lower in children with CeD compared to the control group (Table 1).Clinical demographic and laboratory measures in control subjects and children with CeD.Controls (n = 20)CeD (n = 20)P-valueAge12.83 ± 1.9111.78 ± 1.740.077Duration of disease-4.49 ± 4.02: Height (m)1.44 ± 0.131.38 ± 0.140.125BMI (kg/m2)22.26 ± 5.4718.81 ± 3.900.031Tissue Transglutaminase antibody (U/mL)0 to 312.90(1 to 165)*: Hemoglobin (g/dl)125.50 ± 7.84125.63 ± 7.450.963Platelets × 10^9/L333.75 ± 73.20325.42 ± 77.510.768WBC × 10^9/L7.72 ± 1.986.73 ± 1.890.17125 OHD (ng/mL)59.77 ± 22.4543.50 ± 13.360.014Vitamin B12 (ng/mL)180 to 914321.84 ± 89.40: Folic acid (nmol/L)11.3 to 47.618.60(12.20 to 45.50): Serum Iron (μmol/L)13.65 ± 2.7611.46 ± 7.670.700Data is presented as mean ± SD or median (range), Anti TtG, vitamin B12 and folic acid levels were compared with the normal laboratory range.

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Participants were also excluded in they had corneal pathology, allergy to the eye-drops or previous ocular trauma or surgery in the past six months.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Corneal Langerhans cells in children with celiac disease

Study design awaiting verification · Scientific Reports · 2022

Original publication title

Corneal Langerhans cells in children with celiac disease

Hoda Gad; Ibrahim Mohammed; Saras Saraswathi; Bara Al-Jarrah; Maryam Ferdousi; Ioannis N. Petropoulos; Georgios Ponirakis; Adnan Khan; Parul Singh; Souhaila Al Khodor; Mamoun Elawad; Wesam Almasri; Hatim Abdelrahman; Khalid Hussain; Mohamed A. Hendaus; Fatma Al-Mudahka; Khaled Abouhazima; Anthony K. Akobeng; Rayaz A. Malik

© The Author(s) 2022

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Celiac disease (CeD) is a common small bowel enteropathy characterized by an altered adaptive immune system and increased mucosal antigen presenting cells. This study aims to establish if quantification of corneal Langerhans cells (LCs) using corneal confocal microscopy (CCM) could act as a surrogate marker for antigen presenting cell status and hence disease activity in children with CeD. Twenty children with stable CeD and 20 age-matched controls underwent CCM and quantification of central corneal total, mature and immature LC density.

There was no difference in age (11.78 ± 1.7 vs. 12.83 ± 1.91; P = 0.077) or height (1.38 ± 0.14 vs. 1.44 ± 0.13; P = 0.125). BMI (18.81 ± 3.90 vs. 22.26 ± 5.47; P = 0.031) and 25 OHD levels (43.50 ± 13.36 vs. 59.77 ± 22.45; P = 0.014) were significantly lower in children with CeD compared to controls. The total (33.33(16.67 to 59.37) vs. 51.56(30.21 to 85.42); P = 0.343), immature (33.33(16.67 to 52.08) vs. 44.79(29.17 to 82.29); P = 0.752) and mature (1.56(0 to 5) vs. 1.56(1.04 to 8.33); P = 0.752) LC density did not differ between the CeD and control groups.

However, immature (r = 0.535, P = 0.015), mature (r = 0.464, P = 0.039), and total (r = 0.548, P = 0.012) LC density correlated with age. Immature (r = 0.602, P = 0.038) and total (r = 0.637, P = 0.026) LC density also correlated with tissue transglutaminase antibody (Anti-TtG) levels assessed in 12/20 subjects with CeD. There was no difference in corneal LC density between children with CeD and controls. However, the correlation between corneal LC density and anti-TtG levels suggests a relationship with disease activity in CeD and requires further study.

Authors’ abstract

Celiac disease (CeD) is a common small bowel enteropathy characterized by an altered adaptive immune system and increased mucosal antigen presenting cells. This study aims to establish if quantification of corneal Langerhans cells (LCs) using corneal confocal microscopy (CCM) could act as a surrogate marker for antigen presenting cell status and hence disease activity in children with CeD. Twenty children with stable CeD and 20 age-matched controls underwent CCM and quantification of central corneal total, mature and immature LC density.

There was no difference in age (11.78 ± 1.7 vs. 12.83 ± 1.91; P = 0.077) or height (1.38 ± 0.14 vs. 1.44 ± 0.13; P = 0.125). BMI (18.81 ± 3.90 vs. 22.26 ± 5.47; P = 0.031) and 25 OHD levels (43.50 ± 13.36 vs. 59.77 ± 22.45; P = 0.014) were significantly lower in children with CeD compared to controls. The total (33.33(16.67 to 59.37) vs. 51.56(30.21 to 85.42); P = 0.343), immature (33.33(16.67 to 52.08) vs. 44.79(29.17 to 82.29); P = 0.752) and mature (1.56(0 to 5) vs. 1.56(1.04 to 8.33); P = 0.752) LC density did not differ between the CeD and control groups.

However, immature (r = 0.535, P = 0.015), mature (r = 0.464, P = 0.039), and total (r = 0.548, P = 0.012) LC density correlated with age. Immature (r = 0.602, P = 0.038) and total (r = 0.637, P = 0.026) LC density also correlated with tissue transglutaminase antibody (Anti-TtG) levels assessed in 12/20 subjects with CeD. There was no difference in corneal LC density between children with CeD and controls. However, the correlation between corneal LC density and anti-TtG levels suggests a relationship with disease activity in CeD and requires further study.

Publication and source details

Original title: Corneal Langerhans cells in children with celiac disease

Hoda Gad; Ibrahim Mohammed; Saras Saraswathi; Bara Al-Jarrah; Maryam Ferdousi; Ioannis N. Petropoulos; Georgios Ponirakis; Adnan Khan; Parul Singh; Souhaila Al Khodor; Mamoun Elawad; Wesam Almasri; Hatim Abdelrahman; Khalid Hussain; Mohamed A. Hendaus; Fatma Al-Mudahka; Khaled Abouhazima; Anthony K. Akobeng; Rayaz A. Malik

Scientific Reports · 2022

© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Sidra Internal Research Fund(SIRF 5011029001)Akobeng Anthony K. Biomedical Research Program[BMRP- 5726113101]Malik Rayaz A.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T21:57:41.590908+00:00

DOI: 10.1038/s41598-022-22376-w · PMC9622884